QWP
GILD icon

Quotient Wealth Partners’s Gilead Sciences GILD Stock Holding History

Quotient Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Buy
10,600
+1,599
+18% +$224K 0.04% 98
2025
Q4 		$1.1M Sell
9,001
-119
-1% -$14.5K 0.03% 114
2025
Q3 		$1.01M Buy
9,120
+1,073
+13% +$122K 0.03% 117
2025
Q2 		$892K Buy
8,047
+577
+8% +$61.4K 0.03% 127
2025
Q1 		$837K Sell
7,470
-859
-10% -$88.6K 0.03% 123
2024
Q4 		$769K Sell
8,329
-70
-0.8% -$6.3K 0.03% 129
2024
Q3 		$704K Buy
8,399
+95
+1% +$7.25K 0.02% 141
2024
Q2 		$570K Sell
8,304
-1,846
-18% -$123K 0.02% 160
2024
Q1 		$743K Sell
10,150
-641
-6% -$49.3K 0.03% 135
2023
Q4 		$874K Buy
+10,791
New +$840K 0.03% 133

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Quotient Wealth Partners's GILD Position: Q1 2026 in Review

Quotient Wealth Partners increased its Gilead Sciences (GILD) stake by 18% in Q1 2026, buying an estimated $224K and bringing the position to 10,600 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #98.

Quotient Wealth Partners first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Quotient Wealth Partners held 10,600 shares of Gilead Sciences worth $1.48M as of Q1 2026.
  • Quotient Wealth Partners bought 1,599 Gilead Sciences shares in Q1 2026, an estimated $224K.
  • Gilead Sciences made up 0.04% of Quotient Wealth Partners's portfolio in Q1 2026, its #98 holding.
  • Quotient Wealth Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.